Toll-like receptor agonists induce apoptosis in mouse B-cell lymphoma cells by altering NF-κB activation.

Toll-like receptor agonists induce apoptosis in mouse B-cell lymphoma cells by altering NF-κB activation.
复制标题

DOI:
10.1038/cmi.2013.14
复制
发表时间:
2013-07
影响因子:
24.1
通讯作者:
--
中科院分区:
医学1区
文献类型:
--
作者:

文献摘要

参考文献

被引文献

相似文献

toll样受体9 (TLR9)识别含有未甲基化胞基鸟嘌呤(CpG)序列的微生物DNA,诱导先天免疫反应,促进抗原特异性适应性免疫。最近的研究报道,TLR9配体除了刺激先天免疫外,还能诱导表达TLR9的癌细胞凋亡。为了了解tlr9诱导细胞凋亡的机制,我们比较了含有寡脱氧核苷酸的CpG (CpG ODN)对小鼠淋巴瘤B细胞株CH27和小鼠脾B细胞的影响。CpG ODN抑制CH27淋巴瘤B细胞的组成性增殖并诱导凋亡,而CpG ODN处理的原代B细胞被刺激增殖并从自发凋亡中拯救出来。在淋巴瘤B细胞中,凋亡的诱导需要odn中的CpG基序和TLR9的表达。随着淋巴瘤B细胞的凋亡,Bcl-xl的表达减少,Fas及Fas配体的表达增加。Fas配体中和抗体处理可抑制cpgodn诱导的细胞凋亡。CpG ODN在组成性表达高水平c-Myc的淋巴瘤B细胞中触发NF-κB的短暂激活,同时诱导原代B细胞中NF-κB激活和c-Myc表达的持续增加。NF-κB抑制剂对CH27淋巴瘤B细胞增殖有抑制作用。我们的数据表明,淋巴瘤和原代B细胞对CpG ODN的不同反应是NF-κB活化差异的结果。在CpG odn处理的淋巴瘤B细胞中,NF-κB活化受损改变了NF-κB和c-Myc之间的平衡,诱导Fas/Fas配体依赖性凋亡。
Toll-like receptor 9 (TLR9) recognizes microbial DNA containing unmethylated cytosyl guanosyl (CpG) sequences, induces innate immune responses, and facilitates antigen-specific adaptive immunity. Recent studies reported that in addition to stimulating innate immunity, TLR9 ligands induce apoptosis in TLR9 expressing cancer cells. To understand the mechanism of TLR9-induced apoptosis, we compared the effects of CpG containing oligodeoxynucleotides (CpG ODN) on a mouse lymphoma B cell line CH27 with mouse splenic B cells. CpG ODN inhibited constitutive proliferation and induced apoptosis of CH27 lymphoma B cells, in contrast to CpG ODN-treated primary B cells that were stimulated to proliferate and rescued from spontaneous apoptosis. The induction of apoptosis required CpG motif in ODNs and expression of TLR9 in lymphoma B cells. Accompanying the apoptosis of the lymphoma B cells, there was a decrease in Bcl-xl and an increase in the expression of Fas and Fas ligand. The treatment of Fas ligand neutralizing antibody inhibited CpG ODN-induced apoptosis. CpG ODN triggered a transient activation of NF-κB in the lymphoma B cells that constitutively expressed a high level of c-Myc, while it induced sustained increases in NF-κB activation and c-Myc expression in the primary B cells. Furthermore, NF-κB inhibitor inhibited the proliferation of CH27 lymphoma B cells. Our data suggest that the differential responses of lymphoma and primary B cells to CpG ODN are the result of differences in NF-κB activation. The impaired NF-κB activation in CpG ODN-treated lymphoma B cells alters the balance between NF-κB and c-Myc, inducing Fas/Fas ligand-dependent apoptosis.
DOI: 10.4049/jimmunol.167.9.4878
发表时间: 2001-11-01
影响因子: 4.4
作者:
Ballas, ZK;Krieg, AM;Weiner, GJ
通讯作者: Weiner, GJ
DOI: 10.1126/science.285.5428.736
发表时间: 1999-07-30
期刊: SCIENCE
影响因子: 56.9
作者:
Aliprantis, AO;Yang, RB;Zychlinsky, A
通讯作者: Zychlinsky, A
DOI: 10.1182/blood.v87.7.2615.bloodjournal8772615
发表时间: 1996-04-01
期刊: BLOOD
影响因子: 20.3
作者:
CaligarisCappio, F
通讯作者: CaligarisCappio, F
DOI: 10.1158/0008-5472.can-04-4278
发表时间: 2005-09-01
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Baader, E;Toloczko, A;Jeremias, I
通讯作者: Jeremias, I
DOI: 10.1016/j.bbabio.2006.05.032
发表时间: 2006-09-01
影响因子: 4.3
作者:
Er, Ernine;Oliver, Lisa;Vallette, Francois M.
通讯作者: Vallette, Francois M.